Mark Scott

Mark Scott serves as a Researcher specializing in genomics and epigenetics of rare tumors at a French biomedical research institute, evidenced by his +33140516569 contact number. His work aligns with institutional research themes including Cancer, Immunology, and Technology Platforms.

His research investigates genetic and epigenetic mechanisms driving rare tumor development, utilizing genomic technologies to identify disease-specific mutations and alterations. This work contributes to precision oncology by targeting molecular pathways unique to rare cancers, with emphasis on translating findings into potential therapeutic strategies for understudied tumor types.